Trial Details
COMPLETEDBasic Information
| Clinical ID | c1451 |
|---|---|
| Identifier | NCT00410410 |
| Trial Title | A Study of Abatacept in Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: abatacept (ABA)|DRUG: placebo|DRUG: abatacept |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-12-06 |
|---|---|
| Primary Completion Date | 2025-06-09 |
| Completion Date | 2025-11-09 |